Uçkay Ilker, Chalandon Yves, Sartoretti Pascal, Rohner Peter, Berney Thierry, Hadaya Karine, van Delden Christian
Service of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
Clin Transplant. 2007 Jul-Aug;21(4):577-82. doi: 10.1111/j.1399-0012.2007.00684.x.
Zygomycosis are rare fungal infections occurring mainly in immunocompromised patients. To date only 160 cases have been published in transplant recipients. We report four new cases of zygomycosis in transplant recipients illustrating the large clinical spectrum of this infection: one disseminated infection with heart involvement and one rhinocerebral infection with dissemination in two bone marrow transplant recipients, one cutaneous infection in a liver and one pulmonary infection in a kidney recipient. All cases, except the cutaneous infection that was accessible to surgical resection and a systemic antifungal treatment, were fatal. In transplant recipients cumulating risk factors for zygomycosis, a high index of suspicion is required. Early diagnosis and combining surgery with systemic amphotericin-B are mandatory to improve survival rates.
接合菌病是一种罕见的真菌感染,主要发生在免疫功能低下的患者中。迄今为止,移植受者中仅发表了160例病例。我们报告了4例移植受者发生接合菌病的新病例,说明了这种感染的广泛临床谱:2例骨髓移植受者中,1例发生播散性感染累及心脏,1例鼻脑感染伴播散;1例肝移植受者发生皮肤感染,1例肾移植受者发生肺部感染。除皮肤感染可通过手术切除和全身抗真菌治疗外,所有病例均死亡。对于累积有接合菌病危险因素的移植受者,需要高度怀疑。早期诊断并将手术与全身应用两性霉素B相结合是提高生存率的关键。